Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-10-6
|
pubmed:abstractText |
In vitro depletion of mature pan-T lymphocytes has been widely and successfully used to prevent acute graft-versus-host disease (GVHD) after allogeneic bone-marrow transplantation (BMT). However, this procedure has been associated with a high incidence of graft failure and leukemic relapse. In this pilot study, we evaluated the efficiency of a selective depletion of human marrow T cytotoxic lymphocytes (CD8), a subset essential to induce GVHD in mice. Eleven patients with hematologic malignancies were included (7 HLA-matched BMT, 4 HLA-mismatched BMT). Marrow treatment with 7 anti-CD8 mAbs and rabbit complement resulted in a marked reduction of CD8+ lymphocytes from 15% (median value; range 7%-31%) to 1% (median value; range less than 1%-11%). Acute GVHD was not abolished by this procedure despite postgraft immunosuppression. One patient (HLA-mismatched BMT) rejected his graft and had a full autologous recovery. In conclusion, when compared to the data in the literature, CD8 depletion was shown to be less efficient than pan-T-cell depletion in the prevention of GVHD after allogeneic BMT and was still associated with a major complication associated with this procedure, i.e., graft failure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0934-0874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3076387-Adolescent,
pubmed-meshheading:3076387-Adult,
pubmed-meshheading:3076387-Antibodies, Monoclonal,
pubmed-meshheading:3076387-Bone Marrow,
pubmed-meshheading:3076387-Bone Marrow Transplantation,
pubmed-meshheading:3076387-Child,
pubmed-meshheading:3076387-Cyclosporins,
pubmed-meshheading:3076387-Graft Rejection,
pubmed-meshheading:3076387-Graft vs Host Disease,
pubmed-meshheading:3076387-Histocompatibility Testing,
pubmed-meshheading:3076387-Humans,
pubmed-meshheading:3076387-Immunosuppression,
pubmed-meshheading:3076387-Lymphocyte Depletion,
pubmed-meshheading:3076387-Methotrexate,
pubmed-meshheading:3076387-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1988
|
pubmed:articleTitle |
Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation.
|
pubmed:affiliation |
Marrow Transplant Unit, Institut Paoli-Calmettes, Marseille, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|